195 related articles for article (PubMed ID: 23137020)
1. Safety and hemostatic efficacy of fibrin pad in partial nephrectomy: results of an open-label phase I and a randomized, standard-of-care-controlled phase I/II study.
Nativ O; Patel B; Shen J; Batiller J; Horn S; Hart JC
BMC Nephrol; 2012 Nov; 13():147. PubMed ID: 23137020
[TBL] [Abstract][Full Text] [Related]
2. A Prospective, Single-Blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Soft Tissue Open Surgery.
Lakshman S; Aqua K; Stefanovic A; Djurdjevic S; Nyirády P; Osváth P; Davis R; Bullock A; Chen J; Ibañez J; Barrera G; Navarro-Puerto J;
J Invest Surg; 2020 Mar; 33(3):218-230. PubMed ID: 30303427
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, controlled trial of the efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic surgery.
Fischer CP; Bochicchio G; Shen J; Patel B; Batiller J; Hart JC
J Am Coll Surg; 2013 Sep; 217(3):385-93. PubMed ID: 23969113
[TBL] [Abstract][Full Text] [Related]
4. Safety and Hemostatic Effectiveness of the Fibrin Pad for Severe Soft-Tissue Bleeding During Abdominal, Retroperitoneal, Pelvic, and Thoracic (Non-cardiac) Surgery: A Randomized, Controlled, Superiority Trial.
Koea J; Baldwin P; Shen J; Patel B; Batiller J; Arnaud A; Hart J; Hammond J; Fischer C; James Garden O
World J Surg; 2015 Nov; 39(11):2663-9. PubMed ID: 26041587
[TBL] [Abstract][Full Text] [Related]
5. A Prospective, Randomized, Multicenter Clinical Trial on the Safety and Efficacy of a Ready-to-Use Fibrin Sealant as an Adjunct to Hemostasis during Vascular Surgery.
Chetter I; Stansby G; Sarralde JA; Riambau V; Giménez-Gaibar A; MacKenzie K; Acín F; Navarro-Puerto J;
Ann Vasc Surg; 2017 Nov; 45():127-137. PubMed ID: 28647631
[TBL] [Abstract][Full Text] [Related]
6. A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery.
Koea JB; Batiller J; Patel B; Shen J; Hammond J; Hart J; Fischer C; Garden OJ
HPB (Oxford); 2013 Jan; 15(1):61-70. PubMed ID: 23216780
[TBL] [Abstract][Full Text] [Related]
7. A multicenter clinical trial to evaluate the topical hemostatic efficacy of fibrin sealant in burn patients.
Nervi C; Gamelli RL; Greenhalgh DG; Luterman A; Hansbrough JF; Achauer BM; Gomperts ED; Lee M; Navalta L; Cruciani TR
J Burn Care Rehabil; 2001; 22(2):99-103. PubMed ID: 11302613
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of a dry-powder, fibrin sealant in vascular procedures.
Gupta N; Chetter I; Hayes P; O-Yurvati AH; Moneta GL; Shenoy S; Pribble JP; Zuckerman LA
J Vasc Surg; 2015 Nov; 62(5):1288-95. PubMed ID: 26254451
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of aprotinin-free fibrin sealant versus absorbable hemostat.
Fischer CP; Wood CG; Shen J; Batiller J; Hart JC; Patel B; Albala DM
Clin Appl Thromb Hemost; 2011; 17(6):572-7. PubMed ID: 21873356
[TBL] [Abstract][Full Text] [Related]
10. A prospective, single-blind, randomized, phase III study to evaluate the safety and efficacy of Fibrin Sealant Grifols as an adjunct to hemostasis compared with manual compression in vascular surgery.
Nenezić D; Ayguasanosa J; Menyhei G; Tamás H; Mátyás L; Muluk S; Courtney K; Ibáñez J; Chen J;
J Vasc Surg; 2019 Nov; 70(5):1642-1651. PubMed ID: 30926276
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study.
Lowe J; Luber J; Levitsky S; Hantak E; Montgomery J; Schiestl N; Schofield N; Marra S;
J Cardiovasc Surg (Torino); 2007 Jun; 48(3):323-31. PubMed ID: 17505437
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic effectiveness of Fibrin pad after partial nephrectomy in swine.
Hutchinson RW; Broughton D; Barbolt TA; Poandl T; Muench T; Rockar R; Johnson M; Hart J
J Surg Res; 2011 May; 167(2):e291-8. PubMed ID: 20451926
[TBL] [Abstract][Full Text] [Related]
13. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery.
Saha SP; Muluk S; Schenk W; Burks SG; Grigorian A; Ploder B; Presch I; Pavlova BG; Hantak E
Ann Vasc Surg; 2011 Aug; 25(6):813-22. PubMed ID: 21514114
[TBL] [Abstract][Full Text] [Related]
14. A multicentre, randomized clinical trial comparing the Veriset™ haemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery.
Öllinger R; Mihaljevic AL; Schuhmacher C; Bektas H; Vondran F; Kleine M; Sainz-Barriga M; Weiss S; Knebel P; Pratschke J; Troisi RI
HPB (Oxford); 2013 Jul; 15(7):548-58. PubMed ID: 23458162
[TBL] [Abstract][Full Text] [Related]
15. A multicentre, prospective, randomized, controlled trial comparing EVARREST™ fibrin sealant patch to standard of care in controlling bleeding following elective hepatectomy: anatomic versus non-anatomic resection.
Koea JB; Batiller J; Aguirre N; Shen J; Kocharian R; Bochicchio G; Garden OJ
HPB (Oxford); 2016 Mar; 18(3):221-8. PubMed ID: 27017161
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized multicenter trial of fibrin sealant versus thrombin-soaked gelatin sponge for suture- or needle-hole bleeding from polytetrafluoroethylene femoral artery grafts.
Taylor LM; Mueller-Velten G; Koslow A; Hunter G; Naslund T; Kline R;
J Vasc Surg; 2003 Oct; 38(4):766-71. PubMed ID: 14560228
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a new fibrin sealant with standard topical hemostatic agents.
Schwartz M; Madariaga J; Hirose R; Shaver TR; Sher L; Chari R; Colonna JO; Heaton N; Mirza D; Adams R; Rees M; Lloyd D
Arch Surg; 2004 Nov; 139(11):1148-54. PubMed ID: 15545559
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomized study comparing fibrin sealant to manual compression for the treatment of anastomotic suture-hole bleeding in expanded polytetrafluoroethylene grafts.
Saha SP; Muluk S; Schenk W; Dennis JW; Ploder B; Grigorian A; Presch I; Goppelt A
J Vasc Surg; 2012 Jul; 56(1):134-41. PubMed ID: 22633423
[TBL] [Abstract][Full Text] [Related]
19. The FINISH-3 trial: a phase 3, international, randomized, single-blind, controlled trial of topical fibrocaps in intraoperative surgical hemostasis.
Bochicchio GV; Gupta N; Porte RJ; Renkens KL; Pattyn P; Topal B; Troisi RI; Muir W; Chetter I; Gillen DL; Zuckerman LA; Frohna PA
J Am Coll Surg; 2015 Jan; 220(1):70-81. PubMed ID: 25458801
[TBL] [Abstract][Full Text] [Related]
20. Combination of a liquid fibrin sealant with sheet-type hemostatic agents: experimental evaluation in partial nephrectomy animal model.
Ishii K; Kawashima H; Hayama T; Asai T; Kamikawa S; Sakamoto W; Miyabashira S; Oka S; Sugimoto T
Int J Urol; 2011 Jun; 18(6):478-82. PubMed ID: 21488977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
